Literature DB >> 33336388

Variety of endosomal TLRs and Interferons (IFN-α, IFN-β, IFN-γ) expression profiles in patients with SLE, SSc and MCTD.

A Paradowska-Gorycka1, A Wajda1, B Stypinska1, E Walczuk1, E Rzeszotarska1, M Walczyk2, E Haladyj3, K Romanowska-Prochnicka2,4, A Felis-Giemza2, A Lewandowska2, M Olesińska2.   

Abstract

We investigated Toll-like receptor (TLR)-3/-7/-8/-9 and interferon (IFN)-α/β/γ mRNA expression in whole blood and serum IFN-α/β/γ levels in patients with mixed connective tissue disease (MCTD), systemic lupus erythematosus (SLE) and systemic sclerosis (SSc) and in healthy subjects to assess the association between the TLR-IFN expression and severity of and susceptibility to diseases, and identify potential biomarkers. Expression of the IFN-γ, TLR-3 and TLR-8 was detected only in SLE patients. TLR-7, IFN-α and IFN-β expression was highest in SLE, while TLR-9 expression was highest in SSc patients. In SLE and MCTD patients a strong correlation was observed between TLR-7 and IFN-α expression and IFN-β and IFN-α expression. In MCTD patients, negative correlation between IFN-α and TLR-9 and TLR-7 and TLR-9 was revealed. TLR-9 expression in anti-U1-70k-negative, anti-C negative and anti-SmB-negative MCTD patients was higher than in MCTD-positive patients. We observed negative correlations between serum IFN-α levels and TLR-7 expression and C3 and C4 levels in SLE patients. In SLE patients we observed that with increased IFN-γ, TLR-3 and TLR-8 expression increased the value of C3 and C4. Our results confirmed that the endosomal TLR-IFN pathway seems to be more important in SLE than in MCTD or SSc, and that IFN-α and IFN-β may be possible biomarkers for SLE.
© 2021 British Society for Immunology.

Entities:  

Keywords:  TLR; connective tissue disease; expression; interferon; pathogenesis

Mesh:

Substances:

Year:  2021        PMID: 33336388      PMCID: PMC7944358          DOI: 10.1111/cei.13566

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   5.732


  66 in total

1.  Systemic sclerosis and lupus: points in an interferon-mediated continuum.

Authors:  Shervin Assassi; Maureen D Mayes; Frank C Arnett; Pravitt Gourh; Sandeep K Agarwal; Terry A McNearney; Damien Chaussabel; Nancy Oommen; Michael Fischbach; Kairav R Shah; Julio Charles; Virginia Pascual; John D Reveille; Filemon K Tan
Journal:  Arthritis Rheum       Date:  2010-02

2.  Association of increased interferon-inducible gene expression with disease activity and lupus nephritis in patients with systemic lupus erythematosus.

Authors:  Xuebing Feng; Hui Wu; Jennifer M Grossman; Punchong Hanvivadhanakul; John D FitzGerald; Grace S Park; Xin Dong; Weiling Chen; Michelle H Kim; Haoling H Weng; Daniel E Furst; Alan Gorn; Maureen McMahon; Mihaela Taylor; Ernest Brahn; Bevra H Hahn; Betty P Tsao
Journal:  Arthritis Rheum       Date:  2006-09

3.  Signatures of differentially regulated interferon gene expression and vasculotrophism in the peripheral blood cells of systemic sclerosis patients.

Authors:  F K Tan; X Zhou; M D Mayes; P Gourh; X Guo; C Marcum; L Jin; F C Arnett
Journal:  Rheumatology (Oxford)       Date:  2006-01-17       Impact factor: 7.580

4.  Expression of TLR7, TLR9, JAK2, and STAT3 genes in peripheral blood mononuclear cells from patients with systemic sclerosis.

Authors:  Miša Vreća; Ana Zeković; Nemanja Damjanov; Marina Andjelković; Milena Ugrin; Sonja Pavlović; Vesna Spasovski
Journal:  J Appl Genet       Date:  2017-11-16       Impact factor: 3.240

5.  Sex-specific association of X-linked Toll-like receptor 7 (TLR7) with male systemic lupus erythematosus.

Authors:  Nan Shen; Qiong Fu; Yun Deng; Xiaoxia Qian; Jian Zhao; Kenneth M Kaufman; Yee Ling Wu; C Yung Yu; Yuanjia Tang; Ji-Yih Chen; Wanling Yang; Maida Wong; Aya Kawasaki; Naoyuki Tsuchiya; Takayuki Sumida; Yasushi Kawaguchi; Hwee Siew Howe; Mo Yin Mok; So-Young Bang; Fei-Lan Liu; Deh-Ming Chang; Yoshinari Takasaki; Hiroshi Hashimoto; John B Harley; Joel M Guthridge; Jennifer M Grossman; Rita M Cantor; Yeong Wook Song; Sang-Cheol Bae; Shunle Chen; Bevra H Hahn; Yu Lung Lau; Betty P Tsao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-08-23       Impact factor: 11.205

6.  Type I interferon correlates with serological and clinical manifestations of SLE.

Authors:  M C Dall'era; P M Cardarelli; B T Preston; A Witte; J C Davis
Journal:  Ann Rheum Dis       Date:  2005-04-20       Impact factor: 19.103

7.  Interferon-{beta} inhibits bleomycin-induced lung fibrosis by decreasing transforming growth factor-{beta} and thrombospondin.

Authors:  Arata Azuma; Ying Ji Li; Shinji Abe; Jiro Usuki; Kuniko Matsuda; Satoshi Henmi; Yasushi Miyauchi; Kohei Ueda; Akiko Izawa; Saburo Sone; Shu Hashimoto; Shoji Kudoh
Journal:  Am J Respir Cell Mol Biol       Date:  2004-11-19       Impact factor: 6.914

8.  Serum interferon levels in patients with systemic lupus erythematosus.

Authors:  S R Ytterberg; T J Schnitzer
Journal:  Arthritis Rheum       Date:  1982-04

Review 9.  Interferon target-gene expression and epigenomic signatures in health and disease.

Authors:  Franck J Barrat; Mary K Crow; Lionel B Ivashkiv
Journal:  Nat Immunol       Date:  2019-11-19       Impact factor: 25.606

10.  Association of Blood Concentrations of Complement Split Product iC3b and Serum C3 With Systemic Lupus Erythematosus Disease Activity.

Authors:  Alfred H J Kim; Vibeke Strand; Deepali P Sen; Qiang Fu; Nancy L Mathis; Martin J Schmidt; Robin R Bruchas; Nick R Staten; Paul K Olson; Chad M Stiening; John P Atkinson
Journal:  Arthritis Rheumatol       Date:  2019-01-24       Impact factor: 10.995

View more
  4 in total

1.  Identification of Peptides as Novel Inhibitors to Target IFN-γ, IL-3, and TNF-α in Systemic Lupus Erythematosus.

Authors:  Ghulam Mustafa; Hafiza Salaha Mahrosh; Mahwish Salman; Sumaira Sharif; Raheela Jabeen; Tanveer Majeed; Hafsah Tahir
Journal:  Biomed Res Int       Date:  2021-11-13       Impact factor: 3.411

Review 2.  Cytokines as Biomarkers in Systemic Lupus Erythematosus: Value for Diagnosis and Drug Therapy.

Authors:  Helena Idborg; Vilija Oke
Journal:  Int J Mol Sci       Date:  2021-10-20       Impact factor: 5.923

Review 3.  IFN-γ, should not be ignored in SLE.

Authors:  Wenping Liu; Shumin Zhang; Jibo Wang
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

Review 4.  Exosomes as Crucial Players in Pathogenesis of Systemic Lupus Erythematosus.

Authors:  Yue Fei; Qi Liu; Na Peng; Guocan Yang; Ziwei Shen; Pan Hong; Shengjun Wang; Ke Rui; Dawei Cui
Journal:  J Immunol Res       Date:  2022-07-20       Impact factor: 4.493

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.